Abstract
Background
More than half of patients with hereditary hemochromatosis (HH) have painful arthritis, often including hindfoot osteoarthritis. Total ankle arthroplasty (TAA) is increasingly recommended for patients with painful ankle osteoarthritis. However, the pain relief and function experienced by patients continues to be debated particularly as compared with ankle fusion.
Questions/purposes
We asked whether (1) the complication rates were low; (2) the components were stable; (3) the patients achieved pain relief; and (4) the patients had satisfactory midterm function, ROM, and quality of life.
Patients and Methods
We retrospectively reviewed all 16 prospectively followed patients (21 implants) with HH who underwent ankle arthroplasty. They had an average age of 59.5 years at the time of surgery. We obtained a visual analog scale for pain, the SF-36, and the American Orthopaedic Foot and Ankle Society (AOFAS) hindfoot score. Component stability was assessed using weightbearing radiographs. The minimum followup was 3.1 years (average, 5.3 years; range, 3.1–8.6 years).
Results
Postoperatively, one patient had débridement of a painful cyst on the tibial side and one patient had a subfibular débridement with a lateral ligament reconstruction. The tibial and talar components were stable in all ankles. The average pain score decreased from 6.7 (range, 3–10) to 1.9 (range, 0–4). All eight categories of SF-36 score showed improvement. The hindfoot score increased from 46 (range, 22–67) to 84 (range, 74–94).
Conclusions
Our data suggest TAA in patients with ankle osteoarthritis secondary to HH is associated with a low risk of postoperative complications and produces pain relief and good function.
Level of Evidence
Level IV, therapeutic case series. See Guidelines for Authors for a complete description of levels of evidence.
Similar content being viewed by others
References
Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008; 358:221–230.
Anderson T, Montgomery F, Carlsson A. Uncemented STAR total ankle prostheses: three to eight-year follow-up of fifty-one consecutive ankles. J Bone Joint Surg Am. 2003;85:1321–1329.
Buechel FF Sr, Buechel FF Jr, Pappas MJ. Eighteen-year evaluation of cementless meniscal bearing total ankle replacements. Instr Course Lect. 2002;51:143–151.
Chou LB, Coughlin MT, Hansen S Jr, Haskell A, Lundeen G, Saltzman CL, Mann RA. Osteoarthritis of the ankle: the role of arthroplasty. J Am Acad Orthop Surg. 2008;16:249–259.
Coester LM, Saltzman CL, Leupold J, Pontarelli W. Long-term results following ankle arthrodesis for post-traumatic arthritis. J Bone Joint Surg Am. 2001;83:219–228.
Davies MB, Saxby T. Ankle arthropathy of hemochromatosis: a case series and review of the literature. Foot Ankle Int. 2006;27:902–906.
Fleiss JL. Statistical Methods for Rates and Proportions. Ed 2. New York, NY: John Wiley and Sons, 1981.
Fuchs S, Sandmann C, Skwara A, Chylarecki C. Quality of life 20 years after arthrodesis of the ankle: a study of adjacent joints. J Bone Joint Surg Br. 2003;85:994–998.
Glazebrook M, Daniels T, Younger A, Foote CJ, Penner M, Wing K, Lau J, Leighton R, Dunbar M. Comparison of health-related quality of life between patients with end-stage ankle and hip arthrosis. J Bone Joint Surg Am. 2008;90:499–505.
Gougoulias N, Khanna A, Maffulli N. How successful are current ankle replacements?: a systematic review of the literature. Clin Orthop Relat Res. 2010;468:199–208.
Haddad SL, Coetzee JC, Estok R, Fahrbach K, Banel D, Nalysnyk L. Intermediate and long-term outcomes of total ankle arthroplasty and ankle arthrodesis: a systematic review of the literature. J Bone Joint Surg Am. 2007;89:1899–1905.
Hintermann B, Valderrabano V, Dereymaeker G, Dick W. The HINTEGRA ankle: rationale and short-term results of 122 consecutive ankles. Clin Orthop Relat Res. 2004;424:57–68.
Huskisson EC. Measurement of pain. Lancet. 1974; 2:1127–1131.
Jacki SH, Uhl M, Adler CP, Peter HH, von Kempis J. Predominant ankle arthropathy in hereditary haemochromatosis. Rheumatology (Oxford). 1999;38:378–379.
Karantana A, Martin Geoghegan J, Shandil M, Dhar S. Simultaneous bilateral total ankle replacement using the S.T.A.R.: a case series. Foot Ankle Int. 2010;31:86–89.
Kim BS, Choi WJ, Kim YS, Lee JW. Total ankle replacement in moderate to severe varus deformity of the ankle. J Bone Joint Surg Br. 2009;91:1183–1190.
Kitaoka HB, Alexander IJ, Adelaar RS, Nunley JA, Myerson MS, Sanders M. Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser toes. Foot Ankle Int. 1994;15:349–353.
Kopp FJ, Patel MM, Deland JT, O’Malley MJ. Total ankle arthroplasty with the Agility prosthesis: clinical and radiographic evaluation. Foot Ankle Int. 2006;27:97–103.
Lance EM, Paval A, Fries I, Larsen I, Patterson RL Jr. Arthrodesis of the ankle joint: a follow-up study. Clin Orthop Relat Res. 1979;142:146–158.
Lee KB, Cho SG, Hur CI, Yoon TR. Perioperative complications of HINTEGRA total ankle replacement: our initial 50 cases. Foot Ankle Int. 2008;29:978–984.
Lynch AF, Bourne RB, Rorabeck CH. The long-term results of ankle arthrodesis. J Bone Joint Surg Br. 1988;70:113–116.
Mazur JM, Schwartz E, Simon SR. Ankle arthrodesis. Long-term follow-up with gait analysis. J Bone Joint Surg Am. 1979;61:964–975.
McCurdie I, Perry JD. Haemochromatosis and exercise related joint pains. BMJ. 1999;318:449–451.
McDonnell SM, Preston BL, Jewell SA, Barton JC, Edwards CQ, Adams PC, Yip R. A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment. Am J Med. 1999;106:619–624.
McLaren GD, McLaren CE, Adams PC, Barton JC, Reboussin DM, Gordeuk VR, Acton RT, Harris EL, Speechley MR, Sholinsky P, Dawkins FW, Snively BM, Vogt TM, Eckfeldt JH; Hemochromatosis and Iron Overload Screen (HEIRS) Study Research Investigators. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can J Gastroenterol. 2008;22:923–930.
Morgan CD, Henke JA, Bailey RW, Kaufer H. Long-term results of tibiotalar arthrodesis. J Bone Joint Surg Am. 1985;67:546–550.
Myerson MS, Mroczek K. Perioperative complications of total ankle arthroplasty. Foot Ankle Int. 2003;24:17–21.
Nihal A, Gellman RE, Embil JM, Trepman E. Ankle arthrodesis. Foot Ankle Surg. 2008;14:1–10.
Pagenstert GI, Barg A, Leumann AG, Rasch H, Muller-Brand J, Hintermann B, Valderrabano V. SPECT-CT imaging in degenerative joint disease of the foot and ankle. J Bone Joint Surg Br. 2009;91:1191–1196.
Rihl M, Kellner H. [Arthropathy of hereditary hemochromatosis] [in German]. Z Rheumatol. 2004;63:22–29.
Saltzman CL, Amendola A, Anderson R, Coetzee JC, Gall RJ, Haddad SL, Herbst S, Lian G, Sanders RW, Scioli M, Younger AS. Surgeon training and complications in total ankle arthroplasty. Foot Ankle Int. 2003;24:514–518.
Saltzman CL, el-Khoury GY. The hindfoot alignment view. Foot Ankle Int. 1995;16:572–576.
Saltzman CL, Mann RA, Ahrens JE, Amendola A, Anderson RB, Berlet GC, Brodsky JW, Chou LB, Clanton TO, Deland JT, Deorio JK, Horton GA, Lee TH, Mann JA, Nunley JA, Thordarson DB, Walling AK, Wapner KL, Coughlin MJ. Prospective controlled trial of STAR total ankle replacement versus ankle fusion: initial results. Foot Ankle Int. 2009;30:579–596.
Schmid H, Struppler C, Braun GS, Kellner W, Kellner H. Ankle and hindfoot arthropathy in hereditary hemochromatosis. J Rheumatol. 2003;30:196–199.
Schutte BG, Louwerens JW. Short-term results of our first 49 Scandanavian total ankle replacements (STAR). Foot Ankle Int. 2008;29:124–127.
SooHoo NF, Zingmond DS, Ko CY. Comparison of reoperation rates following ankle arthrodesis and total ankle arthroplasty. J Bone Joint Surg Am. 2007;89:2143–2149.
Valderrabano V, Hintermann B, Dick W. Scandinavian total ankle replacement: a 3.7-year average followup of 65 patients. Clin Orthop Relat Res. 2004;424:47–56.
Valderrabano V, Pagenstert G, Horisberger M, Knupp M, Hintermann B. Sports and recreation activity of ankle arthritis patients before and after total ankle replacement. Am J Sports Med. 2006;34:993–999.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–483.
Wood PL, Deakin S. Total ankle replacement: the results in 200 ankles. J Bone Joint Surg Br. 2003;85:334–341.
Acknowledgments
We thank Richard L. Amendola for assistance in preparing the paper, Heath B. Henninger PhD for helpful discussions, and Christine L. Abraham and Michael D. Harris for correcting the manuscript. We also thank the reviewers and editors (Richard A. Brand MD and Paul A. Lotke MD) for their suggestions for strengthening the work.
Author information
Authors and Affiliations
Corresponding author
Additional information
One or more of the authors (BH) have received royalties from Integra Orthopedics (Plainsboro, NJ), which were given to the research fund at the clinic where the work was performed. One or more of the authors (AB) have received research funding from Swiss Society of Orthopaedics and Basel Foundation Orthopaedic Surgery and Biomechanics of Foot and Ankle.
Each author certifies that his or her institution approved the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
About this article
Cite this article
Barg, A., Elsner, A., Hefti, D. et al. Total Ankle Arthroplasty in Patients with Hereditary Hemochromatosis. Clin Orthop Relat Res 469, 1427–1435 (2011). https://doi.org/10.1007/s11999-010-1483-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-010-1483-5